Journal article
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial
Abstract
BackgroundSystemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. We completed an initial feasibility trial of an online self-administered version of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program using the cohort multiple randomized controlled trial (RCT) design. Due to low intervention offer uptake, we will conduct a new feasibility trial with progression to full-scale …
Authors
Nordlund J; Henry RS; Kwakkenbos L; Carrier M-E; Levis B; Nielson WR; Bartlett SJ; Dyas L; Tao L; Fedoruk C
Journal
Trials, Vol. 22, No. 1,
Publisher
Springer Nature
Publication Date
December 2021
DOI
10.1186/s13063-021-05827-z
ISSN
1468-6708